by Yecuris Corporation | Dec 24, 2019
New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. Minniti et. al., 2019 Study Summary Minniti ME, Pedrelli M, Vedin LL, Delbès AS, Denis RGP, Öörni K, Sala C, Pirazzini C, Thiagarajan D, Nurmi HJ,...
by Rob Copenhaver | Mar 11, 2019
Alirocumab Response in FRG Mice Regulation of Lipoprotein (a) Metabolism by PCSK9 in Animal Models Villard et. al., 2016 Study Summary T. T. T. Tran, E. Villard, B. Poirier, E. Guillot, JC. Le Bail, C. Boixel, D. Boulay, J. Blankenstein, A. Parkar, T. Muslin and P....
